First Command Advisory Services’s Immunovant IMVT Stock Holding History

First Command Advisory Services’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$248	Buy	+10	New	+$259	﹤0.01%	1100

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

First Command Advisory Services's IMVT Position: Q1 2026 in Review

First Command Advisory Services opened a new position in Immunovant (IMVT) in Q1 2026: 10 shares worth $248. The stake represents ﹤0.01% of the portfolio and ranks #1100 among its holdings.

215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

First Command Advisory Services held 10 shares of Immunovant worth $248 as of Q1 2026.
Immunovant was a new First Command Advisory Services position in Q1 2026.
Immunovant made up ﹤0.01% of First Command Advisory Services's portfolio in Q1 2026, its #1100 holding.
215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on First Command Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.